INTERNATIONAL PATENT: BIOMUNEX PHARMACEUTICALS FILES APPLICATION FOR "ANTIBODIES THAT SPECIFICALLY BIND MUCOSAL ASSOCIATED INVARIANT T (MAIT) CELLS"

GENEVA, April 6 -- BIOMUNEX PHARMACEUTICALS (29 rue du Faubourg Saint Jacques75014 PARIS) filed a patent application (PCT/EP2025/077693) for "ANTIBODIES THAT SPECIFICALLY BIND MUCOSAL ASSOCIATED INVARIANT T (MAIT) CELLS" on Sep 26, 2025. With publication no. WO/2026/068750, the details related to the patent application was published on Apr 02, 2026.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): PRIGENT, Julie (c/o Biomunex Pharmaceuticals29 rue du Faubourg Saint Jacques75014 Paris), PLYTE, Simon (c/o Biomunex Pharmaceuticals29 rue du Faubourg Saint Jacques75014 Paris), FRAUDEAU, Marie (c/o Biomu...